Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Barriers Limiting Optical Coherence Tomography Penetration in Actual Clinical Practice & Training (OCT2ACT) Study

NCT07193693 is registered in ClinicalTrials.gov with Consorzio Futuro in Ricerca as lead sponsor.

NCT NCT07193693
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07193693 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Barriers Limiting Optical Coherence Tomography Penetration in Actual Clinical Practice & Training (OCT2ACT) Study
Lead sponsor
Consorzio Futuro in Ricerca
Phase
Observational
Overall status
Recruiting
Start date
September 15, 2025
Completion date
May 15, 2026
Enrollment
1,000 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease (cad) (e.g., angina, myocardial infarction, and atherosclerotic heart disease (ashd))